Free tool
Rare disease stocks
We cover 180 companies grouped under the Rare disease theme. The median market value in the group is $533.37M. Across the group, the median move over the past trading day is +1.72%. 59% of the 173 with a 200-day average trade above it. Price change over the past year runs from −74.2% to +263.3% across the middle 80 percent of the group, with a median of +38.9%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
180 of 268 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| VRTX34.SA | Vertex Pharmaceuticals Incorporated | 88.83 BRL | +19.14% | −85.56% | −83.17% |
| VRTX | Vertex Pharmaceuticals Incorporated | $552.85 | +15.42% | +22.28% | +42.14% |
| ARGX | argenx SE | $1,019.49 | +14.70% | +21.37% | +50.52% |
| A1RG34.SA | argenx SE | 209.16 BRL | +18.17% | +11.37% | +44.49% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $240.08 | −13.76% | −40.01% | −45.88% |
| A1LN34.SA | Alnylam Pharmaceuticals, Inc. | 61.14 BRL | −11.65% | −45.14% | −49.89% |
| INSM | Insmed Incorporated | $123.89 | +18.29% | −30.05% | −3.45% |
| ROIV | Roivant Sciences Ltd. | $36.47 | +5.04% | +66.30% | +213.32% |
| JAZZ | Jazz Pharmaceuticals plc | $260.23 | +1.88% | +50.29% | +108.87% |
| ASND | Ascendis Pharma A/S | $252.99 | −0.17% | +18.61% | +32.89% |
| BBIO | BridgeBio Pharma, Inc. | $80.40 | −4.42% | +2.77% | +70.01% |
| CORT | Corcept Therapeutics Incorporated | $123.57 | +35.61% | +223.48% | +79.56% |
| BMRN | BioMarin Pharmaceutical Inc. | $66.12 | +9.71% | +11.22% | +13.03% |
| B1MR34.SA | BioMarin Pharmaceutical Inc. | 166.77 BRL | +12.08% | −0.14% | +6.36% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $88.88 | +3.92% | +31.11% | +329.16% |
| CYTK | Cytokinetics, Incorporated | $77.46 | −3.92% | +25.48% | +109.29% |
| IONS | Ionis Pharmaceuticals, Inc. | $63.57 | +13.60% | −20.21% | +52.01% |
| KYMR | Kymera Therapeutics, Inc. | $126.64 | +15.07% | +74.05% | +202.82% |
| PTGX | Protagonist Therapeutics, Inc. | $150.59 | +11.09% | +72.73% | +164.75% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $84.86 | +1.20% | +81.60% | +182.02% |
| IMVT | Immunovant, Inc. | $43.50 | +8.51% | +67.89% | +192.14% |
| RYTM | Rhythm Pharmaceuticals, Inc. | $113.35 | +6.80% | +7.94% | +14.26% |
| SRRK | Scholar Rock Holding Corporation | $58.25 | +19.05% | +36.10% | +74.77% |
| ORKA | Oruka Therapeutics, Inc. | $101.82 | +12.88% | +260.17% | +601.72% |
| LQDA | Liquidia Corporation | $70.49 | −16.50% | +124.49% | +168.53% |
| KNSA | Kiniksa Pharmaceuticals International, plc | $80.20 | +26.23% | +90.93% | +142.74% |
| PTCT | PTC Therapeutics, Inc. Common Stock | $73.47 | −3.07% | −4.26% | +49.03% |
| DNTH | Dianthus Therapeutics, Inc. | $112.11 | +7.29% | +182.54% | +378.90% |
| TVTX | Travere Therapeutics, Inc. | $67.01 | +18.23% | +69.56% | +288.91% |
| MIRM | Mirum Pharmaceuticals, Inc. | $98.08 | −14.12% | +25.63% | +36.58% |
| GRFS | Grifols, S.A. | $8.09 | +4.39% | −12.45% | −17.62% |
| DYN | Dyne Therapeutics, Inc. | $26.34 | +2.77% | +42.38% | +102.62% |
| EWTX | Edgewise Therapeutics, Inc. | $44.21 | +6.27% | +86.15% | +209.16% |
| AMLX | Amylyx Pharmaceuticals, Inc. | $37.46 | +92.20% | +228.02% | +340.71% |
| MANE | Veradermics, Incorporated | $102.35 | −8.14% | +171.13% | +171.13% |
| CPRX | Catalyst Pharmaceuticals Inc | $31.49 | 0.00% | +36.03% | +52.72% |
| CLDX | Celldex Therapeutics, Inc. | $41.22 | +15.62% | +52.61% | +87.96% |
| IRON | Disc Medicine, Inc. | $82.41 | +10.45% | +4.20% | +38.71% |
| ARQT | Arcutis Biotherapeutics, Inc. | $24.86 | −10.70% | −14.28% | +58.44% |
| VRDN | Viridian Therapeutics, Inc. | $24.18 | +22.74% | −21.19% | +30.21% |
| PHVS | Pharvaris N.V. | $37.31 | +9.83% | +40.90% | +57.76% |
| RARE | Ultragenyx Pharmaceutical Inc. | $26.46 | −1.60% | +12.12% | −9.60% |
| TRVI | Trevi Therapeutics, Inc. | $17.95 | −0.94% | +50.97% | +146.57% |
| VERA | Vera Therapeutics, Inc. | $35.28 | +0.28% | −27.44% | +65.32% |
| NKTR | Nektar Therapeutics | $74.96 | +5.06% | +72.64% | +176.20% |
| BCRX | BioCryst Pharmaceuticals, Inc. | $9.83 | +2.61% | +31.07% | +17.16% |
| MLYS | Mineralys Therapeutics, Inc. | $26.34 | −3.20% | −26.24% | +78.70% |
| COAG | Hemab Therapeutics Holdings, Inc. | $49.65 | −1.47% | +46.03% | +46.03% |
| AUPH | Aurinia Pharmaceuticals Inc. | $16.75 | +10.05% | +9.12% | +38.03% |
| ZBIO | Zenas BioPharma, Inc. | $33.77 | +2.89% | −2.12% | +103.93% |
| STOK | Stoke Therapeutics, Inc. | $33.46 | +14.16% | +8.28% | +77.32% |
| ADMA | ADMA Biologics, Inc. | $9.72 | +14.62% | −45.64% | −42.86% |
| PVLA | Palvella Therapeutics, Inc. | $148.24 | +4.56% | +47.83% | +195.71% |
| AGIO | Agios Pharmaceuticals, Inc. Common Stock | $33.90 | −8.30% | +24.72% | −9.02% |
| SEPN | Septerna, Inc. | $41.30 | +23.32% | +47.61% | +245.32% |
| ETON | Eton Pharmaceuticals, Inc. | $63.05 | +49.02% | +287.76% | +268.93% |
| ANIP | ANI Pharmaceuticals, Inc. | $75.65 | −3.47% | −3.54% | −16.24% |
| ANAB | AnaptysBio, Inc. | $58.37 | +8.88% | +94.78% | +335.60% |
| AVLN | Avalyn Pharma Inc. | $38.20 | +38.31% | +29.54% | +29.54% |
| MAZE | Maze Therapeutics, Inc. | $30.42 | +6.03% | −23.51% | +128.55% |
| FBRX | Forte Biosciences, Inc. | $76.97 | +0.61% | +226.01% | +580.25% |
| TRAX | First Tracks Biotherapeutics, Inc. | $45.11 | +7.33% | +137.42% | +137.42% |
| XERS | Xeris Biopharma Holdings, Inc. | $8.74 | +6.46% | +18.91% | +12.48% |
| TYRA | Tyra Biosciences, Inc. | $26.69 | −14.07% | −0.37% | +122.42% |
| A2RR34.SA | Arrowhead Pharmaceuticals, Inc. | 58.02 BRL | +4.58% | +25.99% | +301.52% |
| KALV | KalVista Pharmaceuticals Inc | $27.00 | 0.00% | +74.64% | +107.85% |
| OMER | Omeros Corporation | $19.28 | +70.02% | +17.70% | +343.22% |
| JBIO | Jade Biosciences, Inc. | $21.84 | +9.47% | +54.24% | +176.46% |
| MLTX | MoonLake Immunotherapeutics | $15.56 | −21.73% | +30.21% | −71.52% |
| SVRA | Savara Inc. | $5.60 | +3.13% | −0.71% | +78.34% |
| AVTX | Avalo Therapeutics, Inc. | $19.74 | +1.23% | +15.98% | +110.00% |
| WVE | Wave Life Sciences, Inc. | $5.25 | −11.32% | −67.08% | −47.18% |
| CLYM | Climb Bio Inc | $17.84 | +39.48% | +375.73% | +619.35% |
| DSGN | Design Therapeutics, Inc. | $15.68 | +31.99% | +72.31% | +201.54% |
| ANNX | Annexon, Inc. | $5.15 | +0.39% | +9.81% | +139.53% |
| DBVT | DBV Technologies S.A. | $14.97 | +7.70% | −21.42% | +52.91% |
| SLN | Silence Therapeutics plc | $13.67 | +13.26% | +122.28% | +170.16% |
| PHAR | Pharming Group N.V. | $11.46 | −11.93% | −33.14% | −19.75% |
| STTK | Shattuck Labs, Inc. | $8.06 | +14.49% | +117.25% | +710.87% |
| TECX | Tectonic Therapeutic, Inc. | $37.71 | +23.20% | +80.34% | +53.48% |
| IRWD | Ironwood Pharmaceuticals, Inc. | $4.39 | +12.28% | +2.81% | +245.67% |
| ASMB | Assembly Biosciences, Inc. | $35.33 | +36.36% | +4.68% | +32.72% |
| ZVRA | Zevra Therapeutics, Inc. | $12.04 | +24.00% | +44.36% | +28.63% |
| AGMB | AgomAb Therapeutics NV | $14.02 | +12.07% | −4.30% | −4.30% |
| GYRE | Gyre Therapeutics, Inc. | $6.68 | +8.97% | −1.91% | −18.54% |
| CRMD | CorMedix Inc. | $8.56 | +12.63% | −29.61% | −37.65% |
| VALN | Valneva SE | $6.78 | +36.69% | −24.29% | −28.10% |
| ZURA | Zura Bio Limited | $6.32 | +17.47% | +13.87% | +208.29% |
| AQST | Aquestive Therapeutics, Inc. | $5.08 | +36.19% | −21.24% | +31.61% |
| SPRY | ARS Pharmaceuticals, Inc. | $5.72 | −0.69% | −50.22% | −57.66% |
| KMDA | Kamada Ltd. Ordinary Shares | $8.63 | +23.46% | +26.48% | +26.12% |
| EPRX | Eupraxia Pharmaceuticals Inc. | $7.42 | +20.26% | −1.98% | +41.87% |
| EPRX.TO | Eupraxia Pharmaceuticals Inc. | 10.20 CAD | +16.70% | −2.49% | +41.67% |
| QTTB | Q32 Bio Inc. | $16.32 | +7.30% | +374.42% | +728.43% |
| RZLT | Rezolute, Inc. | $5.01 | +1.42% | +131.41% | −28.43% |
| AVIR | Atea Pharmaceuticals, Inc. | $5.43 | +12.66% | +56.03% | +48.36% |
| LRMR | Larimar Therapeutics, Inc. | $4.16 | +8.62% | +19.88% | +11.83% |
| XFOR | X4 Pharmaceuticals, Inc. | $4.16 | +5.58% | +6.94% | +4.79% |
| ENTA | Enanta Pharmaceuticals, Inc. | $14.08 | +10.60% | −2.36% | +62.59% |
| UPB | Upstream Bio, Inc. | $7.18 | +12.19% | −73.48% | −57.08% |
| IKT | Inhibikase Therapeutics, Inc. | $2.50 | +6.38% | +28.21% | +42.05% |
| PRQR | ProQR Therapeutics N.V. | $2.38 | +37.57% | +19.60% | +5.78% |
| IFRX | InflaRx N.V. | $2.46 | +44.71% | +125.69% | +167.10% |
| TRDA | Entrada Therapeutics, Inc. | $7.62 | +25.33% | −24.18% | +35.35% |
| TTRX | Turn Therapeutics Inc. | $9.73 | +25.06% | +107.46% | +39.00% |
| FULC | Fulcrum Therapeutics, Inc. | $3.86 | +3.49% | −64.65% | −39.78% |
| SION | Sionna Therapeutics, Inc. | $6.25 | −86.23% | −84.06% | −74.02% |
| ELDN | Eledon Pharmaceuticals, Inc. | $3.47 | −2.80% | +114.20% | +35.02% |
| CAMP | CAMP4 THERAPEUTICS CORPORATION | $4.45 | +30.12% | −25.83% | +185.26% |
| IVVD | Invivyd, Inc. | $0.94 | +53.89% | −62.45% | +67.62% |
| AKBA | Akebia Therapeutics, Inc. | $0.96 | −25.12% | −38.17% | −68.37% |
| SLGL | Sol-Gel Technologies Ltd. | $81.72 | +2.37% | +93.88% | +289.14% |
| RNA | Prosensa Holding B.V. Ordinary Shares | $14.00 | +21.00% | −5.08% | −5.08% |
| PEPG | PepGen Inc. | $3.43 | +80.26% | −52.23% | +161.45% |
| CRDL | Cardiol Therapeutics Inc. | $2.00 | +73.16% | +101.21% | +75.44% |
| CRDL.TO | Cardiol Therapeutics Inc. | 2.76 CAD | +68.29% | +102.94% | +72.50% |
| KROS | Keros Therapeutics, Inc. | $11.68 | +14.40% | −37.00% | −20.87% |
| ANTX | AN2 Therapeutics, Inc. | $5.66 | +14.81% | +409.91% | +403.11% |
| SIGA | SIGA Technologies, Inc. | $3.04 | −1.94% | −45.19% | −60.50% |
| ARMP | Armata Pharmaceuticals, Inc. | $5.56 | +7.96% | −15.24% | +113.85% |
| MSLE | Satellos Bioscience Inc. | $9.40 | −0.58% | +51.52% | +82.17% |
| MSCL.TO | Satellos Bioscience Inc. | 13.00 CAD | −2.26% | +54.76% | +80.56% |
| PLX | Protalix BioTherapeutics, Inc. | $2.41 | +0.42% | +38.51% | +50.62% |
| SPRB | Spruce Biosciences, Inc. | $63.40 | +50.99% | −30.10% | +697.48% |
| MDWD | MediWound Ltd. | $12.97 | −10.24% | −29.59% | −24.81% |
| AARD | Aardvark Therapeutics, Inc. | $7.25 | +8.37% | −45.03% | −19.80% |
| UNCY | Unicycive Therapeutics, Inc. | $5.47 | +6.63% | −5.69% | +27.51% |
| MIST | Milestone Pharmaceuticals Inc. | $1.16 | +2.65% | −43.41% | −31.36% |
| EQ | Equillium, Inc. | $2.18 | −11.38% | +42.48% | +14.74% |
| CPIX | Cumberland Pharmaceuticals Inc. | $8.70 | +59.59% | +118.59% | +166.87% |
| INO | Inovio Pharmaceuticals, Inc. | $1.29 | +32.99% | −23.67% | −33.85% |
| MDP.TO | Medexus Pharmaceuticals Inc. | 5.15 CAD | +3.83% | +66.67% | +80.70% |
| RFL | Rafael Holdings, Inc. | $2.24 | −1.75% | +77.78% | +52.38% |
| PTHS | Pelthos Therapeutics Inc. | $27.20 | −1.41% | −7.64% | +20.41% |
| PYPD | PolyPid Ltd. | $5.10 | +28.14% | +17.24% | +47.83% |
| GOSS | Gossamer Bio, Inc. | $0.20 | +2.76% | −92.90% | −91.33% |
| FBIO | Fortress Biotech, Inc. | $2.83 | −13.46% | −29.78% | +23.58% |
| PLYX | Polaryx Therapeutics, Inc. | $1.87 | −4.59% | −94.66% | −94.66% |
| RLYB | Rallybio Corporation | $16.89 | +3.53% | +198.53% | +262.65% |
| TENX | Tenax Therapeutics, Inc. | $2.32 | −85.67% | −79.00% | −60.81% |
| TELO | Telomir Pharmaceuticals, Inc. | $1.18 | −4.07% | −11.94% | −19.18% |
| FBIOP | Fortress Biotech, Inc. | $18.30 | −2.66% | +80.12% | +141.55% |
| SPRO | Spero Therapeutics, Inc. | $1.23 | +4.24% | −47.66% | −33.51% |
| RNTX | Rein Therapeutics Inc. | $0.80 | +2.30% | −36.00% | −32.20% |
| IMA | ImageneBio, Inc. | $5.55 | −0.89% | −17.90% | −60.78% |
| ATYR | aTyr Pharma, Inc. | $0.57 | +16.33% | −24.90% | −88.95% |
| SCYX | SCYNEXIS, Inc. | $5.19 | +45.38% | +712.21% | +514.20% |
| NSRX | Nasus Pharma Ltd. | $4.10 | +32.69% | −45.70% | −48.69% |
| MCRB | Seres Therapeutics, Inc. | $5.00 | +3.09% | −67.00% | −74.00% |
| GRCE | Grace Therapeutics, Inc. | $2.20 | −4.35% | −39.89% | −32.31% |
| MREO | Mereo BioPharma Group plc | $0.28 | −6.75% | −44.78% | −83.82% |
| EDSA | Edesa Biotech, Inc. | $4.45 | −16.82% | +196.67% | +83.88% |
| QNCX | Quince Therapeutics, Inc. | $30.93 | +73.28% | +3.10% | +95.76% |
| NNVC | NanoViricides, Inc. | $1.29 | −16.23% | +6.61% | −12.84% |
| BRNS | Barinthus Biotherapeutics plc | $0.66 | +9.82% | −10.20% | −44.77% |
| JSPR | Jasper Therapeutics, Inc. | $0.72 | +3.78% | −60.86% | −75.67% |
| TVRD | Tvardi Therapeutics, Inc. | $1.82 | −28.35% | −55.39% | −93.77% |
| RVX.TO | Resverlogix Corp. | 0.11 CAD | −4.55% | +5.00% | +5.00% |
| COCP | Cocrystal Pharma, Inc. | $1.13 | +22.83% | +14.14% | −26.62% |
| VYNE | VYNE Therapeutics Inc | $28.56 | +3080.40% | +4824.14% | +8687.69% |
| KTTA | Pasithea Therapeutics Corp. | $0.56 | +24.44% | −52.94% | −21.90% |
| CALC | CalciMedica, Inc. | $0.59 | −16.36% | −91.28% | −78.92% |
| CMMB | Chemomab Therapeutics Ltd. | $2.30 | +61.97% | +28.49% | −33.91% |
| HIND | Vyome Holdings, Inc. | $2.23 | +11.50% | −37.18% | −80.23% |
| QNRX | Quoin Pharmaceuticals, Ltd. | $5.07 | +18.18% | −63.99% | −31.02% |
| AZTR | Azitra, Inc. | $0.16 | +23.05% | −43.55% | −78.97% |
| IMRN | Immuron Limited | $1.14 | +7.55% | +43.40% | −36.84% |
| SNGX | Soligenix, Inc. | $0.41 | +12.53% | −71.47% | −87.06% |
| XCUR | Exicure, Inc. | $1.19 | −32.00% | −78.67% | −79.90% |
| INM | InMed Pharmaceuticals Inc. | $1.44 | −12.20% | +28.57% | −35.43% |
| PULM | Pulmatrix, Inc. | $1.60 | −7.51% | −29.20% | −67.81% |
| JAGX | Jaguar Health, Inc. | $0.92 | −7.51% | −97.35% | −98.52% |
| CVKD | Cadrenal Therapeutics, Inc. | $1.53 | −25.73% | −79.13% | −87.58% |
| GLMD | Galmed Pharmaceuticals Ltd. | $4.31 | +716.94% | +423.12% | +205.34% |
| GRI | GRI Bio, Inc. | $1.96 | +40.00% | −75.00% | −95.14% |
| XRTX | XORTX Therapeutics Inc. | $2.26 | +11.88% | −20.70% | −44.74% |
| SXTP | 60 Degrees Pharmaceuticals, Inc. | $1.13 | −28.03% | −45.25% | −78.10% |
| MTNB | Matinas BioPharma Holdings, Inc. | $0.20 | −40.57% | −68.18% | −90.82% |
| APLI.TO | Appili Therapeutics Inc. | 0.02 CAD | +50.00% | −40.00% | −25.00% |
| VBIO | Valion Bio, Inc. | $0.16 | −43.82% | −88.80% | −95.00% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.